Differential microRNA Expression by Solexa Sequencing in the Sera of Ovarian Cancer Patients |
Ji, Ting
(Institute of Bioengineering, Zhejiang Sci-Tech University)
Zheng, Zhi-Guo (Zhejiang Cancer Research Institute, Zhejiang Cancer Hospital) Wang, Feng-Mei (Women's Hospital, School of Medcine, Zhejiang University) Xu, Li-Jian (Institute of Bioengineering, Zhejiang Sci-Tech University) Li, Lu-Feng (Institute of Bioengineering, Zhejiang Sci-Tech University) Cheng, Qi-Hui (Department of Gynaecology and Obstetrics, Hangzhou First People's Hospital) Guo, Jiang-Feng (Institute of Bioengineering, Zhejiang Sci-Tech University) Ding, Xian-Feng (Institute of Bioengineering, Zhejiang Sci-Tech University) |
1 | Creighton C, Reid J, Gunaratne P (2009). Expression profiling of microRNAs by deep sequencing. Brief Bioinform, 10, 490-7. DOI |
2 | Chen Y, Zhang L, Hao Q (2013). Candidate microRNA biomarkers in human epithelial ovarian cancer: systematic review profiling studies and experimental validation. Cancer Cell Int, 13, 2867-86. |
3 | Corney D, Nikitin A (2008). MicroRNA and ovarian cancer. Histol and Histopathol, 23, 1161-9. |
4 | Cortez M, Calin G (2009). MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin Biol Ther, 9, 703-11. DOI |
5 | Dahiya N, Sherman-Baust C, Wang T, et al (2008). MicroRNA expression and identification of putative miRNA targets in ovarian cancer. PLoS One 18, e2436. |
6 | Fu X, Tian J, Zhang L, et al (2012). Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells. FEBS Lett, 9, 1279-86. |
7 | Garmire L, Subramaniam S (2012). Evaluation of normalization methods in mammalian microRNA-Seq data, RNA, 18, 1279-88. DOI |
8 | Liu X, Liu L, Xu Q (2012). MicroRNA as a novel drug target for cancer therapy. Expert Opin Biol Th, 12, 573-80. DOI ScienceOn |
9 | Mitchell P, Parkin R, Kroh E, et al (2008). Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA, 105, 10513-8. DOI ScienceOn |
10 | Moxon S, Jing R, Szittya G, et al (2008). Deep sequencing of tomato short RNAs identifies microRNAs targeting genes involved in fruit ripening. Genome Res, 18, 1602-9. DOI ScienceOn |
11 | Nam E, Yoon H, Kim S, et al (2008), MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res, 14, 2690-5. DOI ScienceOn |
12 | Rathjen T, Pais H, Sweetman D, et al (2009). High throughput sequencing of microRNAs in chicken somites. FEBS Lett, 583, 1422-6. DOI ScienceOn |
13 | Resnick K, Alder H, Hagan J, et al (2009). The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol, 112, 55-9. DOI ScienceOn |
14 | Kurman R, Visvanathan K, Roden R, et al (2008). Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis. Am J Obstet Gynecol, 198, 351-6. DOI ScienceOn |
15 | Iorio M, Croce C (2012). MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med, 4, 143-59. DOI |
16 | Iorio M, Croce C (2012). microRNA involvement in human cancer. Carcinogenesis, 33, 1126-33. DOI |
17 | Iorio M, Visone R, Di Leva G, Donati V, et al (2007). MicroRNA signatures in human ovarian cancer. Cancer Res, 67, 8699-707. DOI ScienceOn |
18 | Bartel D (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-97. DOI ScienceOn |
19 | Brase J, Wuttig D, Kuner R, et al (2010), Serum microRNAs as non-invasive biomarkers for cancer. Mol Cancer, 9, 306-15. DOI ScienceOn |
20 | Calin G, Croce C (2006). MicroRNA signatures in human cancers.Nat Rev Cancer 6, 857-66. DOI ScienceOn |
21 | Smith, R. Brooks C, et al (2013). Cancer screening in the United States. CA Cancer J Clin, 2, 87-105. |
22 | Xu YZ, Xi QH, Ge WL, Zhang XQ (2013). Identification of serum microrna-21 as a biomarker for early detection and prognosis in human epithelial ovarian cancer. Asian Pac J Cancer Prev, 14, 1057-60. DOI ScienceOn |
23 | Ries L, Reichman M, Lewis D, et al (2003). Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program. Oncologist, 8, 541-52. DOI ScienceOn |
24 | Van M, Helleman J, Berns E, et al (2010). MicroRNAs in ovarian cancer biology and therapy resistance. Int J Biochem Cell B, 42, 1282-90. DOI ScienceOn |
25 | Rossing M, . Wicklund K, Cushing-Haugen K, et al (2010). Predictive value of symptoms for early detection of ovarian cancer. J Natl Cancer Inst, 102, 222-229. DOI ScienceOn |
26 | Sankaranarayanan R, Ferlay J (2006). Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Cl OB, 20, 207-25. |
27 | Siegel R, Naishadham D, Jemal A (2013). Cancer statistics. CA Cancer J Clin, 63, 11-30. DOI ScienceOn |
28 | Visintin I, Feng Z, Longton G, et al (2008). Diagnostic markers for early detection of ovarian cancer. Clin Cancer Res, 14, 1065-72. DOI ScienceOn |
29 | Visone R, Croce C (2008). MicroRNA. Wiley Encyclopedia of Chemical Biology, 5, 1-9. |
30 | Wan, SM, Lv F, et al (2012). Identification of genes and microRNAs involved in ovarian carcinogenesis. Asian Pac J Cancer P, 13, 3997-4000. DOI ScienceOn |
31 | Wu Q, Lu Z, Li H, et al (2011). Next-generation sequencing of microRNAs for breast cancer detection. J Biomed Biotechnology. 2011, 597145-52. |
32 | Wyman S, Parkin R, Mitchell P, et al (2009). Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries. PLoS One, 4, e5311. DOI ScienceOn |
33 | Lee R, Ambros V (2001). An extensive class of small RNAs in Caenorhabditis elegans. Science, 294, 862-864. DOI ScienceOn |
34 | Li J, Liang S, Lu X (2010). Potential role of ezrin and its related microRNA in ovarian cancer invasion and metastasis. Zhonghua Fu Chan Ke Za Zhi, 45, 787-92. |
35 | Livak K, Schmittgen T (2001), Analysis of relative gene expression data using real-time quantitative PCR and the 2-[Delta][Delta] CT method. Methods 25, 402-8. DOI ScienceOn |
36 | Chen X, Ba Y, Ma L, et al (2008). Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res, 18, 997-1006. DOI ScienceOn |